当前位置: X-MOL 学术Cancer Discov. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
mSWI/SNF Component ARID1A Mediates Breast Cancer Treatment Response.
Cancer Discovery ( IF 28.2 ) Pub Date : 2020-03-01 , DOI: 10.1158/2159-8290.cd-rw2020-011
American Association for Cancer Research

ARID1A is required for response of ER+ breast cancer cells to tamoxifen and fulvestrant but not JQ1.

中文翻译:

mSWI / SNF组件ARID1A介导乳腺癌治疗反应。

ARID1A是ER +乳腺癌细胞对他莫昔芬和氟维司群(而不是JQ1)的反应所必需的。
更新日期:2020-03-01
down
wechat
bug